Description
A potent PPARα agonist (EC50 = 10 nM in a transactivation assay using HEK293 cells); selective for PPARα over PPARγ (EC50 = 4,100 nM) as well as over a panel of human nuclear hormone receptors (EC50s = >25 μM); reduces plasma triglyceride levels and increases HDL levels in human ApoA1 transgenic mice from 10-100 mg/kg; reduces serum triglyceride and LDL levels in hamsters fed a high-fat diet,
Formal name: N-[[3-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methoxy]phenyl]methyl]-N-(methoxycarbonyl)-glycine
Synonyms:
Molecular weight: 444.9
CAS: 1000998-59-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Cardiovascular System|Lipids & Lipoproteins|Lipoproteins||Research Area|Endocrinology & Metabolism|Hormones & Receptors|PPARs||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias